TRPC5 Channel Inhibition Protects Podocytes in Puromycin-Aminonucleoside Induced Nephrosis Models

Yiming Zhou; Yiming Zhou; Choah Kim; Juan Lorenzo B. Pablo; Fan Zhang; Ji Yong Jung; Ji Yong Jung; Li Xiao; Silvana Bazua-Valenti; Silvana Bazua-Valenti; Maheswarareddy Emani; Corey R. Hopkins; Astrid Weins; Anna Greka; Anna Greka

doi:10.3389/fmed.2021.721865

Frontiers in Medicine (Sep 2021)

TRPC5 Channel Inhibition Protects Podocytes in Puromycin-Aminonucleoside Induced Nephrosis Models

Yiming Zhou,
Yiming Zhou,
Choah Kim,
Juan Lorenzo B. Pablo,
Fan Zhang,
Ji Yong Jung,
Ji Yong Jung,
Li Xiao,
Silvana Bazua-Valenti,
Silvana Bazua-Valenti,
Maheswarareddy Emani,
Corey R. Hopkins,
Astrid Weins,
Anna Greka,
Anna Greka

Affiliations

Yiming Zhou: Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States
Yiming Zhou: Center for the Development of Therapeutics (CDoT), Broad Institute of MIT and Harvard, Cambridge, MA, United States
Choah Kim: Center for the Development of Therapeutics (CDoT), Broad Institute of MIT and Harvard, Cambridge, MA, United States
Juan Lorenzo B. Pablo: Center for the Development of Therapeutics (CDoT), Broad Institute of MIT and Harvard, Cambridge, MA, United States
Fan Zhang: Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States
Ji Yong Jung: Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States
Ji Yong Jung: Department of Internal Medicine, Gachon University Gil Medical Center, College of Medicine, Incheon, South Korea
Li Xiao: Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States
Silvana Bazua-Valenti: Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States
Silvana Bazua-Valenti: Center for the Development of Therapeutics (CDoT), Broad Institute of MIT and Harvard, Cambridge, MA, United States
Maheswarareddy Emani: Center for the Development of Therapeutics (CDoT), Broad Institute of MIT and Harvard, Cambridge, MA, United States
Corey R. Hopkins: Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE, United States
Astrid Weins: Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States
Anna Greka: Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States
Anna Greka: Center for the Development of Therapeutics (CDoT), Broad Institute of MIT and Harvard, Cambridge, MA, United States

DOI: https://doi.org/10.3389/fmed.2021.721865
Journal volume & issue: Vol. 8

Abstract

Read online

Podocyte injury and the appearance of proteinuria are key features of several progressive kidney diseases. Genetic deletion or selective inhibition of TRPC5 channels with small-molecule inhibitors protects podocytes in rodent models of kidney disease, but less is known about the human relevance and translatability of TRPC5 inhibition. Here, we investigate the effect of TRPC5 inhibition in puromycin aminonucleoside (PAN)-treated rats, human iPSC-derived podocytes, and kidney organoids. We first established that systemic administration of the TRPC5 inhibitor AC1903 was sufficient to protect podocyte cytoskeletal proteins and suppress proteinuria in PAN-induced nephrosis rats, an established model of podocyte injury. TRPC5 current was recorded in the human iPSC-derived podocytes and was blocked by AC1903. PAN treatment caused podocyte injury in human iPSC-derived podocytes and kidney organoids. Inhibition of TRPC5 channels reversed the effects of PAN-induced injury in human podocytes in both 2D and 3D culture systems. Taken together, these results revealed the relevance of TRPC5 channel inhibition in puromycin-aminonucleoside induced nephrosis models, highlighting the potential of this therapeutic strategy for patients.

Published in Frontiers in Medicine

ISSN: 2296-858X (Online)
Publisher: Frontiers Media S.A.
Country of publisher: Switzerland
LCC subjects: Medicine: Medicine (General)
Website: http://www.frontiersin.org/journals/medicine

About the journal

Abstract

Keywords